Clinical Trials Directory

Trials / Completed

CompletedNCT04244162

Postoperative Neurocognitive Disorders

Mechanisms Mediating Postoperative Neurocognitive Disorders

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the mechanisms of brain injury contributing to postoperative neurocognitive disorders (PNCD) in an at-risk population (obstructive sleep apnea (OSA)) undergoing surgery. The investigators will enroll 50 OSA patients scheduled for surgery. All patients will have a brain scan (fMRI) within five days before surgery and two days and six months after surgery. During this visit cognitive function will be assessed using the Wide Range Assessment of Memory and Learning (WRAML2) and Montreal Cognitive Assessment (MoCA) tests. Patients will also be asked to participate in a blood draw during the first 2 visits for fMRI (within five days of surgery and two days after surgery). The Confusion Assessment Method (CAM-S) test, will be used to examine postoperative delirium.

Detailed description

The investigators will examine the potential mechanisms of brain injury contributing to postoperative neurocognitive disorders (PNCD) in an at-risk population (obstructive sleep apnea (OSA)). This study proposes that neuro-inflammation is associated with measurable tissue changes that can be examined with MD measures and blood biomarkers. On the day of surgery, standard of care procedures will take place. Hemodynamic vitals will be continuously monitored. As per the latest guidelines and recommendations from the American Society of Anesthesiologists (ASA), mean arterial pressure (MAP) will be targeted to \> 60 mmHg or within 20% of baseline values, and processed EEG-guided anesthesia will be monitored to maintain a patient state index between 20-50. Electronic medical records and intraoperative integrated physiologic waveform will be collected. In summary, the investigators will examine the potential mechanisms of brain injury contributing to postoperative delirium (POD) and acute and long-lasting neurocognitive deficits in an at-risk population (OSA).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBrain ImagingMagnetic resonance imaging (MRI) using diffusion tensor imaging (DTI)-based mean diffusivity (MD) measures.
DIAGNOSTIC_TESTCognitive testingWide Range Assessment of Memory and Learning (WRAML2), Montreal Cognitive Assessment (MoCA), and Confusion Assessment Method for the ICU -severity (CAM-ICU S) tests.
DIAGNOSTIC_TESTBlood BiomarkersInflammatory markers

Timeline

Start date
2020-12-12
Primary completion
2024-12-31
Completion
2025-08-31
First posted
2020-01-28
Last updated
2025-11-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04244162. Inclusion in this directory is not an endorsement.

Postoperative Neurocognitive Disorders (NCT04244162) · Clinical Trials Directory